Home › Funds › GENERATION INVESTMENT MANAGEMENT LLP › WST

GENERATION INVESTMENT MANAGEMENT LLP position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

GENERATION INVESTMENT MANAGEMENT LLP reported holding 2,028,322 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q2 2026 13F filing — a position valued at US$728.2M, representing 7.08% of its reported portfolio and ranking #5 among its reported holdings. GENERATION INVESTMENT MANAGEMENT LLP has disclosed WST holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)2.03M sh
Reported value held$728.17M
Portfolio Weight7.08%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GENERATION INVESTMENT MANAGEMENT LLP's WST position evolved

GENERATION INVESTMENT MANAGEMENT LLP first disclosed a stake in WST in Q2 2025 at 1,165,777 shares (US$255.1M). The position peaked in Q2 2026 at 2,028,322 shares, worth US$728.2M. Across 5 filings, GENERATION INVESTMENT MANAGEMENT LLP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,028,322 shares valued at US$728.2M — a reduction of -215,654 shares quarter over quarter.. Notable position changes include a 60% increase in Q4 2025 (shares fell 9% over the following quarter), a 44% increase in Q1 2026 (shares rose 43% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 1.17M $255.07M New
Q3 2025 976.01K $256.04M Reduce
Q4 2025 1.56M $429.73M Add
Q1 2026 2.24M $562.43M Add
Q2 2026 2.03M $728.17M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 34 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), BROWN ADVISORY INC (US$386.0M), Longview Partners (Guernsey) LTD (US$371.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has GENERATION INVESTMENT MANAGEMENT LLP held WST?

GENERATION INVESTMENT MANAGEMENT LLP has disclosed WST holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is GENERATION INVESTMENT MANAGEMENT LLP's current position in WST?

As of Q2 2026, GENERATION INVESTMENT MANAGEMENT LLP holds 2.03M shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $728.17M, representing 7.08% of its reported portfolio and ranking #5.

Has GENERATION INVESTMENT MANAGEMENT LLP been buying or selling WST?

In the latest 13F filing (Q2 2026), GENERATION INVESTMENT MANAGEMENT LLP reduced its position in WST. The position peaked in Q2 2026 at 2.03M shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, BROWN ADVISORY INC, Longview Partners (Guernsey) LTD, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.